Amarin Corp. Sitting At Session Lows (AMRN)

Amarin Corp. AMRN are having a very poor trading session and are currently sitting at their lows for the day. The stock has lost 5.25% to $8.39. There does not appear to be any significant news out that is driving the activity in the stock. Amarin Corporation plc (Amarin) is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease. The Company's development programs capitalize in the field of lipid science and the therapeutic benefits of essential fatty acids in cardiovascular disease.